ST
ALXN

Stifel Trust’s Alexion Pharmaceuticals ALXN Stock Holding History

Stifel Trust’s Portfolio ALXN Stock Details ALXN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q3 		$1.79M Buy
10,776
+5,376
+100% +$883K 0.34% 91
2014
Q2 		$844K Buy
5,400
+490
+10% +$77.4K 0.16% 123
2014
Q1 		$747K Buy
4,910
+4,695
+2,184% +$747K 0.14% 126
2013
Q4 		$29K Buy
+215
New +$25.8K 0.01% 315

Other funds holding ALXN

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Stifel Trust's ALXN Position: Q3 2014 in Review

Stifel Trust increased its Alexion Pharmaceuticals (ALXN) stake by 100% in Q3 2014, buying an estimated $883K and bringing the position to 10,776 shares worth $1.79M. The position accounts for 0.34% of the portfolio, ranked #91.

Stifel Trust first reported a position in ALXN in Q4 2013 and has held it in 4 quarters since. 521 funds tracked by Wall St. Rank hold ALXN as of Q3 2014.

  • Stifel Trust held 10,776 shares of Alexion Pharmaceuticals worth $1.79M as of Q3 2014.
  • Stifel Trust bought 5,376 Alexion Pharmaceuticals shares in Q3 2014, an estimated $883K.
  • Alexion Pharmaceuticals made up 0.34% of Stifel Trust's portfolio in Q3 2014, its #91 holding.
  • Stifel Trust first reported a position in Alexion Pharmaceuticals in Q4 2013 and has held it in 4 quarters since.
  • 521 funds tracked by Wall St. Rank held Alexion Pharmaceuticals as of Q3 2014.

Based on Stifel Trust's 13F filing for Q3 2014, filed 14 Nov 2014.